About the MMRF
The MMRF is the largest nonprofit in the world focused on accelerating the cure for multiple myeloma. Our work is not done until each and every multiple myeloma patient has the answers they need. With our exceptional leadership, strategic collaboration and uniquely innovative approach, we are on the path to finding a cure for multiple myeloma.
Our mission
To discover and advance a cure for each and every multiple myeloma patient.
Our Culture
Urgency
Innovation
Results
See how our work is changing cancer research
Patient founded, patient-focused

The Multiple Myeloma Research Foundation (MMRF) was founded in 1998 by identical twin sisters Kathy Giusti and Karen Andrews soon after Kathy was diagnosed with multiple myeloma. With limited research funding, no effective treatments and few clinical trials in the pipeline, the life expectancy of the rare and fatal cancer was only 3 years.
Frustrated by the lack of treatments available to her, Kathy developed an innovative new approach to cancer research rooted in disrupting the status quo. Employing rigorous business models to create significant change, she has been instrumental in establishing collaborative research initiatives and opening clinical trials that are dramatically accelerating new treatments for myeloma patients and making immense progress in the field of multiple myeloma. She now uses her unique approach to work to defeat all cancer types as Co-Chair of the HBS Kraft Precision Medicine Accelerator, a $20M endowed program provided by Robert Kraft and the Kraft Family Foundation. Kathy is a champion of patient engagement, open access to medical data and advancing the business of sequencing. At HBS, she is part of a group of best-in-class leaders from across science, business and technology, speeding breakthroughs in precision medicine for all cancers.
Meet our leaders
Financials
An extraordinary 90% of the MMRF total budget goes directly into research and related programming, consistently earning us top rankings from the nation’s leading charity evaluators. See our accreditations.
